90% of Drug Developments Fail — Why That's About to Change!

In this episode, Shashi Ramaiah discusses how outdated drug development practices and regulatory complexity can slow innovation and delay patient access to new therapies. He explains how SPECCRO combines traditional drug development expertise with emerging technologies such as AI, machine learning, organoids, and advanced in vitro models to improve decision-making, reduce risk, and accelerate development timelines. The conversation explores the challenges facing biotech startups, the importance of practical problem-solving, and how collaboration and new technologies are helping shape the future of medicine.

Chapters:

00:00 The Challenge of Drug Development

04:00 Bridging Innovation and Regulation

08:43 Integrating New Approaches in Drug Development

12:28 The Role of Speccro in Drug Development

18:40 Building a Team and Client Relationships

23:23 Leveraging Technology and Data

28:18 Onboarding Clients and Problem Solving

31:28 Future Aspirations and Resilience in Startups

Guest Information:

Guest's Name: Shashi Ramaiah